Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Vet Rec ; 164(18): 550-5, 2009 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-19411684

RESUMEN

Four groups of six specific pathogen-free (SPF) pigs were inoculated intranasally with Actinobacillus pleuropneumoniae serotype 2 and treated with either enrofloxacin, tetracycline or penicillin at the onset of clinical disease, or left untreated. A fifth group was left uninoculated. The inoculated control and the penicillin-treated groups developed severe disease, but the groups treated with enrofloxacin and tetracycline recovered rapidly. All the inoculated pigs, except those treated with enrofloxacin developed serum antibodies to A pleuropneumoniae. On day 28, all five groups were challenged with A pleuropneumoniae without any subsequent treatment. The previously uninoculated control group and the enrofloxacin-treated group developed severe disease, but the three seropositive groups remained unaffected.


Asunto(s)
Infecciones por Actinobacillus/veterinaria , Actinobacillus pleuropneumoniae/efectos de los fármacos , Antibacterianos/uso terapéutico , Enfermedades Respiratorias/veterinaria , Enfermedades de los Porcinos/prevención & control , Infecciones por Actinobacillus/inmunología , Infecciones por Actinobacillus/prevención & control , Actinobacillus pleuropneumoniae/inmunología , Animales , Anticuerpos Antibacterianos/sangre , Modelos Animales de Enfermedad , Enrofloxacina , Eutanasia Animal , Fluoroquinolonas/uso terapéutico , Penicilinas/uso terapéutico , Enfermedades Respiratorias/inmunología , Enfermedades Respiratorias/prevención & control , Organismos Libres de Patógenos Específicos , Porcinos , Enfermedades de los Porcinos/inmunología , Enfermedades de los Porcinos/microbiología , Tetraciclina/uso terapéutico
2.
Acta Vet Scand ; 43(4): 231-45, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12831176

RESUMEN

The ability of feed related measures to prevent or reduce post weaning diarrhoea (PWD) was examined in a split litter study including 30 pigs from 6 litters allotted into 5 groups. Four groups were exposed to 3 pathogenic strains of E. coli via the environment at weaning. Three of them were given zinc oxide, lactose+fibres or non-pathogenic strains of E. coil as probiotics. The challenged and the unchallenged control groups were given a standard creep feed. Diarrhoea was observed in all challenged groups but not among uninfected animals, and the incidence of diarrhoea was lower in the group given nonpathogenic E. coli compared to all other challenged groups. The severity of PWD also differed between litters. When corrected for mortality due to PWD, a decreased incidence of diarrhoea was also seen in the groups given zinc oxide or lactose+fibres. The dominating serotype of E. coil within faecal samples varied from day to day, also among diarrhoeic pigs, indicating that diarrhoea was not induced by one single serotype alone. The diversity of the faecal coliform populations decreased in all piglets during the first week post weaning, coinciding with an increased similarity between these populations among pigs in the challenged groups. This indicated an influence of the challenge strains, which ceased during the second week. The group given lactose+fibres was least affected with respect to these parameters. In conclusion feed related measures may alleviate symptoms of PWD.


Asunto(s)
Diarrea/veterinaria , Infecciones por Escherichia coli/veterinaria , Escherichia coli/patogenicidad , Probióticos/administración & dosificación , Enfermedades de los Porcinos/microbiología , Enfermedades de los Porcinos/prevención & control , Alimentación Animal , Animales , Animales Lactantes , Diarrea/microbiología , Diarrea/prevención & control , Suplementos Dietéticos , Escherichia coli/clasificación , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Lactosa/administración & dosificación , Índice de Severidad de la Enfermedad , Porcinos , Enfermedades de los Porcinos/patología , Resultado del Tratamiento , Óxido de Zinc/administración & dosificación
3.
Artículo en Inglés | MEDLINE | ID: mdl-11254099

RESUMEN

The aims of this study were to describe the variation in concentration of antibodies to Mycoplasma hyopneumoniae in the serum and colostrum of sows, and to compare the amount of antibodies in colostrum with that obtained in the serum of the smallest piglets in a litter. In addition, the efficacy of the passive immunity in natural conditions was studied. The study was performed in a sow pool herd (600 sows) that was endemically infected with M. hyopneumoniae. Blood samples were collected from sows 19 days (n = 25) before and 3 days (n = 15) after farrowing, and a colostrum sample (n = 25) was collected on the day of farrowing. All samples were analysed for antibodies to M. hyopneumoniae with a monoclonal blocking enzyme-linked immunosorbent assay (ELISA). Twelve sows (48%) were high-responders with respect to antibody concentration in colostrum. The amount of blocking decreased in serum during the last weeks of pregnancy and 3 days post-farrowing it was only 53% of the level found in colostrum. At the age of 14 days, 30 of the smallest piglets were weaned. They were divided into three experimental groups, being the offspring of high-responding sows, low-responding sows, or a mix of high- and low-responding sows. The groups were transported to three separated isolation units and were followed until slaughter. At slaughter, lung lesions were not found. Nor could M. hyopneumoniae be demonstrated either by cultivation or by polymerase chain reaction. However, a significant increase in absorbance values, assessed by an indirect-ELISA, was demonstrated in groups established from low-responding sows. It was concluded that a high antibody level in colostrum appeared to protect piglets from M. hyopneumoniae.


Asunto(s)
Anticuerpos Antibacterianos/análisis , Calostro/inmunología , Inmunidad Materno-Adquirida , Transmisión Vertical de Enfermedad Infecciosa/veterinaria , Mycoplasma pneumoniae/inmunología , Neumonía Porcina por Mycoplasma/veterinaria , Enfermedades de los Porcinos/inmunología , Animales , Animales Lactantes , Anticuerpos Antibacterianos/sangre , Ensayo de Inmunoadsorción Enzimática/veterinaria , Femenino , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Neumonía Porcina por Mycoplasma/inmunología , Neumonía Porcina por Mycoplasma/prevención & control , Neumonía Porcina por Mycoplasma/transmisión , Embarazo , Porcinos , Enfermedades de los Porcinos/prevención & control , Enfermedades de los Porcinos/transmisión
4.
J Appl Microbiol ; 87(4): 564-73, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10583685

RESUMEN

The effect of a dietary supplementation of zinc oxide (ZnO) on the stability of the intestinal flora and on the composition of coliforms in weaned pigs was investigated. Faecal floras were characterized by their metabolic activities and fermentative capacity (FC) using the Phene Plate generalized microplate. Coliforms were characterized by conventional enumeration and by the Phene Plate-RS plates. The latter measured FC, phenotypic diversity, persistence of each coliform strain in piglets, and similarity among the coliform populations within groups. From weaning onwards, the control pigs (n = 5) were fed a basal diet ad libitum, while experimental pigs (n = 5) were given the same food supplemented with 2500 ppm ZnO. Metabolic fingerprinting of faecal floras indicated marked differences between the composition of floras of treated and control pigs during the first 2 weeks post-weaning. The FC of faecal flora in both groups decreased as pigs aged, but it was significantly (P

Asunto(s)
Suplementos Dietéticos , Enterobacteriaceae/crecimiento & desarrollo , Intestinos/microbiología , Óxido de Zinc/farmacología , Animales , Animales Recién Nacidos , Enterobacteriaceae/clasificación , Heces/química , Heces/microbiología , Fenotipo , Porcinos , Destete , Óxido de Zinc/metabolismo
5.
Zentralbl Veterinarmed B ; 46(4): 249-60, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10379235

RESUMEN

SPF pigs aged 10 weeks were infected intranasally with Actinobacillus pleuropneumoniae serotype 2. After the onset of clinical symptoms of respiratory disease, which occurred 20 h post-infection, parenteral treatment with ceftiofur, danofloxacin, enrofloxacin, penicillin or tiamulin was initiated (n = 8 per group). Untreated groups, of which one was infected, served as controls. The uninfected control group did not show any signs of disease, while the infected control group was severely affected by the infection and also expressed a decreased weight gain following the challenge. Based on clinical signs, the magnitude of pathological lesions in the respiratory tract found at necropsy performed 17 days post-infection and the number of reisolates of A. pleuropneumoniae made at necropsy, treatments with the quinolones (danofloxacin and enrofloxacin) and the cephalosporine (ceftiofur) were superior to those with penicillin and tiamulin. The latter groups also developed antibodies to A. pleuropneumoniae to a larger extent. Some of the pigs treated with ceftiofur and danofloxacin developed antibodies to A. pleuropneumoniae, and the microbe was reisolated from approximately 50% of these animals. In contrast, pigs treated with enrofloxacin did not develop antibodies to A. pleuropneumoniae, and the challenge strain was not found at necropsy. The performance with respect to daily weight gain and feed conversion corresponded well with the clinical signs developed and the findings made at necropsy. The decreased growth recorded during the acute phase of the disease was, to a large extent, caused by a reduced feed intake.


Asunto(s)
Infecciones por Actinobacillus/veterinaria , Actinobacillus pleuropneumoniae , Antibacterianos/uso terapéutico , Fluoroquinolonas , Enfermedades Pulmonares/veterinaria , Enfermedades de los Porcinos/tratamiento farmacológico , Infecciones por Actinobacillus/tratamiento farmacológico , Infecciones por Actinobacillus/patología , Actinobacillus pleuropneumoniae/aislamiento & purificación , Animales , Antiinfecciosos/uso terapéutico , Peso Corporal , Cefalosporinas/uso terapéutico , Diterpenos/uso terapéutico , Enrofloxacina , Pulmón/patología , Enfermedades Pulmonares/tratamiento farmacológico , Enfermedades Pulmonares/microbiología , Enfermedades Pulmonares/patología , Penicilinas/uso terapéutico , Quinolonas/uso terapéutico , Porcinos , Enfermedades de los Porcinos/sangre , Enfermedades de los Porcinos/patología , Aumento de Peso
6.
Zentralbl Veterinarmed B ; 46(4): 261-9, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10379236

RESUMEN

The present study was aimed at scrutinizing the efficacy of oral antimicrobial treatments at experimental challenge using a strain of Actinobacillus pleuropneumoniae serotype 2 known to cause severe disease. SPF pigs aged 10 weeks were infected intranasally and the antimicrobial treatments were initiated 5 h prior to that exposure. Several antimicrobial drugs, as well as the length of the treatment period, were elucidated. The outcome of the challenge was monitored by registration of clinical symptoms, weight gains and the development of serum antibodies to A. pleuropneumoniae. At necropsy, the magnitude of pathological lesions in the respiratory tract and the rate of reisolation of the infective strain were recorded. Animals that became diseased displayed a decreased growth rate caused, to a large extent, by a reduced feed intake. The performance with respect to daily weight gain and feed conversion corresponded well with the clinical signs developed and serologic reactions, as well as with the findings made at necropsy. The results obtained among pigs treated with enrofloxacin, but also with florfenicol or chlortetracycline, were superior to those of pigs treated with penicillin, tiamulin or tilmicosin. A positive effect was obtained using a strategic in-feed medication against infection with A. pleuropneumoniae. Provided that the drug used is effective against the target microbe, initiating treatment prior to infection appeared to be more important than the length of the treatment. It should, however, be remembered that A. pleuropneumoniae was reisolated from all but one medicated group following an experimental challenge given after initiating the medication. Consequently medical treatment as described did not eradicate the microbe.


Asunto(s)
Infecciones por Actinobacillus/veterinaria , Actinobacillus pleuropneumoniae , Antibacterianos/uso terapéutico , Fluoroquinolonas , Macrólidos , Enfermedades de los Porcinos/tratamiento farmacológico , Infecciones por Actinobacillus/tratamiento farmacológico , Infecciones por Actinobacillus/fisiopatología , Administración Oral , Animales , Antibacterianos/administración & dosificación , Antiinfecciosos/administración & dosificación , Antiinfecciosos/uso terapéutico , Clortetraciclina/administración & dosificación , Clortetraciclina/uso terapéutico , Diterpenos/administración & dosificación , Diterpenos/uso terapéutico , Enrofloxacina , Penicilina V/administración & dosificación , Penicilina V/uso terapéutico , Quinolonas/administración & dosificación , Quinolonas/uso terapéutico , Porcinos , Enfermedades de los Porcinos/fisiopatología , Tianfenicol/administración & dosificación , Tianfenicol/análogos & derivados , Tianfenicol/uso terapéutico , Tilosina/administración & dosificación , Tilosina/análogos & derivados , Tilosina/uso terapéutico
7.
Res Vet Sci ; 64(3): 225-31, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9690608

RESUMEN

The uptake and distribution of zinc in tissues and the effects of 2500 ppm dietary zinc oxide on health, faecal microflora, and the functions of circulating neutrophils were evaluated in weaned pigs. One group was fed a zinc supplement diet and another group was used as a control. All pigs remained healthy throughout the study, but the supplemented animals showed better performance than the controls. The serum zinc values rose rapidly. At autopsy, carried out at the age of 63 days, the zinc concentrations in liver tissue were 4.5 times higher, and in renal tissue two times higher in the supplemented group than in controls (P<0.001). Microscopic examination showed increased lipid accumulation in hepatocytes from supplemented pigs. No effect on the number of excreted Escherichia coli and enterococci per gram faeces or on the functions of circulating neutrophils was observed. Dietary supplementation with 2500 ppm ZnO for up to two weeks after weaning appears to be potentially beneficial in the prevention of postweaning diarrhoea in pigs.


Asunto(s)
Heces/microbiología , Alimentos Fortificados , Neutrófilos/fisiología , Porcinos/fisiología , Aumento de Peso/efectos de los fármacos , Óxido de Zinc/farmacología , Óxido de Zinc/farmacocinética , Alimentación Animal , Animales , Brachyspira/aislamiento & purificación , Ciego , Clostridium perfringens/aislamiento & purificación , Enterococcus/aislamiento & purificación , Escherichia coli/aislamiento & purificación , Hígado Graso/inducido químicamente , Hígado Graso/patología , Hígado Graso/veterinaria , Femenino , Hiperplasia , Mucosa Intestinal/citología , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Músculo Esquelético/metabolismo , Neutrófilos/efectos de los fármacos , Rotavirus/aislamiento & purificación , Enfermedades de los Porcinos/inducido químicamente , Enfermedades de los Porcinos/patología , Distribución Tisular , Destete , Óxido de Zinc/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA